Trial intelligence / Profile preview

Gradual vs Immediate Remifentanil Withdrawal in Thyroid Surgery

NCT03110653Completed

Sponsor
Université libre de Bruxelles
Start
Apr 2017
Primary completion
Aug 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of remifentanil in postoperative pain (2 arms), sponsored by Université libre de Bruxelles. Primary endpoint: First demand of postoperative analgesic. Started Apr 2017; status: completed.

02

Drugs

remifentanil
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03110653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03110653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call